A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 7, 2018

Primary Completion Date

June 14, 2020

Study Completion Date

December 25, 2020

Conditions
Head and Neck NeoplasmChemoradiotherapy
Interventions
DRUG

SZKJT(San-Zhong-Kui-Jian-Tang)

The SZKJT samples were made and packed by Kaiser Pharmaceutical Co. Ltd. with lot number of 2019023247.

Trial Locations (1)

404327

China Medical University Hospital, Taichung

All Listed Sponsors
lead

China Medical University Hospital

OTHER

NCT05590650 - A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients | Biotech Hunter | Biotech Hunter